Search Results

Aperiomics, today announced the appointment of Elizabeth P. Pyle and Michelle Strobeck to the positions of Chief Operating Officer and Lead Clinical Laboratory Technologist, respectively.

Aperiomics, a biotechnology company deploying advanced technologies to identify the root causes of infectious disease, announced today that it expects to more than double its COVID-19 PCR testing capacity thanks to critical support from the Howard Hughes Medical Institute’s Janelia Research Campus, located in Ashburn, Virginia

Aperiomics, today announced the appointment of Dr. C. Alexander Valencia, PhD to the position of Chief Clinical Officer, where he will oversee clinical test development, validations, regulatory affairs and operations on behalf of the company.

Innovator in metagenomic testing partners with leading biotech companies to increase critical COVID-19 testing capacity immediately

Aperiomics, a biotech company that harnesses the power of deep next-generation sequencing to identify all known pathogens in a single test, today announced that it is partnering with Milenia Labs to further expand its international outreach.

VentureSouth Leads Group of Investors in Groundbreaking Infectious Disease Identification Technology

Winners to be Revealed May 22 at the Industry Awards Celebration

Winners to be Revealed May 22 at the Industry Awards Celebration